These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment]. Mahfoud F, Vonend O, Bruck H, Clasen W, Eckert S, Frye B, Haller H, Hausberg M, Hoppe UC, Hoyer J, Hahn K, Keller T, Krämer BK, Kreutz R, Potthoff SA, Reinecke H, Schmieder R, Schwenger V, Kintscher U, Böhm M, Rump LC, Arbeitsgemeinschaft Herz und Niere der Deutschen Gesellschaftfür Kardiologie – Herz- und Kreislaufforschunge V und der Deutschen Gesellschaft für Nephrologiee V sowie der Deutschen Hochdruckliga e V DHL® – DeutscheGesellschaft für Hypertonie und Prävention. Dtsch Med Wochenschr; 2011 Nov; 136(47):2418. PubMed ID: 22048949 [Abstract] [Full Text] [Related]
28. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H. Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098 [Abstract] [Full Text] [Related]
29. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency. Lauder L, Ewen S, Tzafriri AR, Edelman ER, Cremers B, Kulenthiran S, Ukena C, Linz D, Kindermann I, Tsioufis C, Scheller B, Böhm M, Mahfoud F. Cardiovasc Revasc Med; 2018 Feb; 19(7 Pt B):845-851. PubMed ID: 29555535 [Abstract] [Full Text] [Related]
30. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au. Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086 [Abstract] [Full Text] [Related]
31. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Lancet; 2014 Feb 15; 383(9917):622-9. PubMed ID: 24210779 [Abstract] [Full Text] [Related]
33. The effect of two different renal denervation strategies on blood pressure in resistant hypertension: Comparison of full-length versus proximal renal artery ablation. Chen W, Ling Z, Du H, Song W, Xu Y, Liu Z, Su L, Xiao P, Yuan Y, Lu J, Zhang J, Li Z, Shao J, Zhong B, Zhou B, Woo K, Yin Y. Catheter Cardiovasc Interv; 2016 Nov 15; 88(5):786-795. PubMed ID: 27219520 [Abstract] [Full Text] [Related]
37. Does the presence of accessory renal arteries affect the efficacy of renal denervation? Id D, Kaltenbach B, Bertog SC, Hornung M, Hofmann I, Vaskelyte L, Sievert H. JACC Cardiovasc Interv; 2013 Oct 15; 6(10):1085-91. PubMed ID: 24156968 [Abstract] [Full Text] [Related]